Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Higher-Dose Clotting Factor Prophylaxis Does Not Reduce Postpartum Hemorrhage in Women with von Willebrand Disease
Jan 16, 2026, 04:51

Higher-Dose Clotting Factor Prophylaxis Does Not Reduce Postpartum Hemorrhage in Women with von Willebrand Disease

Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared a post on X:

“ Higher-Dosed Clotting Factor Prophylaxis Fails to Reduce Postpartum Hemorrhage in Women With von Willebrand Disease.

Findings from the Observational Pregnancy and Inherited bleeding DisordErS study (PRIDES).”

Read the full study here.

Title: Higher-Dosed Clotting Factor Prophylaxis Fails to Reduce Postpartum Hemorrhage in Women With von Willebrand Disease: Findings from the Observational PRegnancy and Inherited bleeding DisordErS study (PRIDES)

Authors: Anne de Vaan,  Jeroen Eikenboom, Marieke Kruip,  Marieke Punt, Saskia Schols, Floor Heubel-Moenen, Michiel Coppens,  Laurens Nieuwenhuizen,  Anja Mäkelburg,  Marjolein Peters, Hans Duvekot, Annemieke Middeldorp,  Professor Kitty Bloemenkamp, Professor Roger Schutgens,  Professor Titia Lely,  Karin van Galen

Higher-Dose Clotting Factor Prophylaxis Does Not Reduce Postpartum Hemorrhage in Women with von Willebrand Disease

Find latest scientific updates in Hemostasis Today.